Finance

Lists
Why is NRXP down 5,20%?
Dive Deeper
NRXP:NASDAQ
NRX Pharmaceuticals Inc
2,70 $
-5,20%
(-0,15) 1D
13 қаз., 15:12:17 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXP...
Open
2,85 $
High
2,85 $
Low
2,68 $
Mkt. cap
116,98 млн
Avg. vol.
614,49 м.
Volume
402,48 м.
52-wk high
5,06 $
52-wk low
1,62 $
EPS
-0,74 $
Beta
2,08
Shares outstanding
43,30 млн
No. of employees
29
Open
2,85 $
High
2,85 $
Low
2,68 $
Mkt. cap
116,98 млн
Avg. vol.
614,49 м.
Volume
402,48 м.
52-wk high
5,06 $
52-wk low
1,62 $
EPS
-0,74 $
Beta
2,08
Shares outstanding
43,30 млн
No. of employees
29
News stories
From web sources and news partners
About NRX Pharmaceuticals Inc
CEO-
Employees29
Founded2015
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitenrxpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to NRXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRXP in the last 3 months.
Highest
Current 2,70 $
50,00 $ (+1 750,62%)
Average
35,00 $ (+1 195,43%)
Lowest
10,00 $ (+270,12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
50,00 $
+1 750,6%
09/30/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
45,00 $
+1 565,6%
09/21/2026
Thomas Shrader
BTIG
Buy
Maintained
10,00 $
+270,1%
09/14/2026
Elemer Piros
Lucid Capital
Buy
Initiated
49,00 $
+1 713,6%
05/13/2026
Jason Kolbert
D. Boral Capital
Buy
Maintained
34,00 $
+1 158,4%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
242,00 м.
983,00 м.
1,07 млн
1,10 млн
Cost of goods sold
97,00 мың
408,00 м.
631,00 м.
675,00 м.
Cost of revenue
97,00 мың
408,00 м.
631,00 м.
675,00 м.
Research and development expenses
1,43 млн
558,00 м.
1,31 млн
2,12 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,81 млн
4,57 млн
3,81 млн
4,74 млн
Operating expense
4,26 млн
5,17 млн
5,18 млн
6,93 млн
Total operating expenses
4,36 млн
5,58 млн
5,82 млн
7,60 млн
Operating income
-4,12 млн
-4,59 млн
-4,75 млн
-6,50 млн
Other non operating income
-366,00 м.
1,59 млн
3,54 млн
-9,78 млн
EBT including unusual items
-5,89 млн
360,00 м.
-1,43 млн
-16,52 млн
EBT excluding unusual items
-4,48 млн
-3,67 млн
-1,44 млн
-16,52 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5,89 млн
360,00 м.
-1,43 млн
-16,52 млн
Net profit margin
-2 433,88%
36,62%
-133,90%
-1 500,45%
Earnings per share
-0,51
0,18
-0,04
-0,24
Interest and investment income
2,00 мың
4,00 мың
5,00 мың
6,00 мың
Interest expense
-
-671,00 м.
-233,00 м.
-240,00 м.
Net interest expenses
2,00 мың
-667,00 м.
-228,00 м.
-234,00 м.
Depreciation and amortization charges
26,00 мың
42,00 мың
63,00 мың
66,00 мың
EBITDA
-4,11 млн
-4,55 млн
-4,68 млн
-6,43 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары